VitaFlow™ Transcatheter Aortic Valve System Post-market Study-The LAUNCH Study

Recruiting now

Conditions studied: Aortic Valve Stenosis

In brief

The study objective is to evaluate safety and effectiveness/performance of the Microport™ CardioFlow VitaFlow™ Transcatheter Aortic Valve System for the treatment of severe aortic stenosis in the real world settings.

Key facts

Study ID
NCT04414865
Run by
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
People needed
100
Starts
2020-04-26
Expected to finish
2027-12-30
Last updated by the study team
2020-06-04

Who can join

Age: 70 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.